• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Brain Edema

Brain Edema - 22 Studies Found

Terminated : Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE)
:
  • Peritumoral Brain Edema
  • PRIMARY MALIGNANT and METASTATIC BRAIN
    : 2008-06-02
    : Drug: Xerecept
Withdrawn : XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
:
  • Brain Edema
  • Brain Tumor

: 2005-09-23
:
  • Drug: hCRF hCRF 2mg/day; dexam

Completed : Swiss Prospective Autologous Bone Flap Resorption Study
: Brain Edema
: 2014-12-10
: Procedure: Reimplantation of cryoconserved bone flap A bone flap, which was explanted for decompression
Completed : Correlation of Measured and Calculated Serum Osmolality During Hyperosmolar Drugs Infusion in Patients After Craniotomy
: Brain Edema
: 2014-01-13
:
  • Drug: 20% mannitol solution, 125 ml, IV infusion in 15 min

Completed : XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors
:
  • Brain Edema
  • Brain Tumor

: 2004-07-20
:
  • Drug: hCRF hCRF ; open-label d

Completed : Comparison of the Application in Traumatic Brain Edema Between EIT and Non-invasive ICP Monitoring
:
  • Brain Electrical Impedance;
  • Non-invasive Intracranial Pressure

: 2013-12-23
:
  • Device: EIT monitoring
  • Device: non-invasiv

Withdrawn : Study of Stroke Related Edema Treatments
:
  • Acute Cerebrovascular Accident
  • Cerebral Edema

: 2013-09-26
:
  • Drug: Conivaptan Intravenous c

Completed : Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593)
:
  • Cerebral Edema
  • Brain Metastases

: 2015-05-28
:
  • Drug: Glyburide 1.25mg, twice

Terminated : Tolerability Study of Xerecept® in Pediatric Patients
:
  • Brain Edema
  • Brain Tumor

: 2011-06-07
: Drug: XERECEPT BID dosing, subcutaneous for 1 year O
Completed : An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies
:
  • Brain Edema
  • Brain Tumor

: 2005-09-23
: Drug: hCRF [XERECEPT (corticorelin acetate injection)] 2mg/day
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.